Skip to main content

Russell Investments Group, Ltd.

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1692234 Seattle, WA

Position in APLS

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$0
+$0 QoQ
Shares Held
44,757
+347.7% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 44,757
2025-12-31 9,998
2025-09-30 9,901
2025-06-30 9,925
2025-03-31 38,903
2024-12-31 6,107
2024-09-30 3,231
2024-06-30 4,482
2024-03-31 3,586
2023-12-31 256
2023-09-30 35,471
2023-06-30 137,527
2023-03-31 138,200
2022-12-31 71,875
2022-09-30 88,140
2022-06-30 48,058
2022-03-31 47,749
2021-12-31 107,951
2021-09-30 124,434
2021-06-30 76,308
2021-03-31 94,971
2020-12-31 41,019
2020-09-30 92,361
2020-06-30 34,421
2020-03-31 21,929